Clinical Trials
3 trialsNCT02866955 2020-03-09
EFESE
Institut de Cancérologie de Lorraine
Phase 2 Completed
NCT02853071 2019-11-18
BEST
Centre Hospitalier Universitaire de Besancon
Phase 2 Withdrawn
NCT00003066 2014-01-06
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown